共 15 条
[4]
Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study[J] . McGill,Janet B,Sloan,Lance,Newman,Jennifer,Patel,Sanjay,Sauce,Christophe,von Eynatten,Maximilian,Woerle,Hans-Juergen.Diabetes Care . 2013 (2)
[6]
Efficacy of GLP-1 Receptor Agonists and DPP-4 Inhibitors: Meta-Analysis and Systematic Review[J] . Vanita R. Aroda,Robert R. Henry,Jenny Han,Wenying Huang,Mary Beth DeYoung,Tamara Darsow,Byron J. Hoogwerf.Clinical Therapeutics . 2012 (6)
[7]
Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice[J] . Masanori Abe,Kazuyoshi Okada,Masayoshi Soma.Current Drug Metabolism . 2011 (1)
[10]
Prevalence and Factors Associated With CKD: A Population Study From Beijing[J] . LuXia Zhang,PuHong Zhang,Fang Wang,Li Zuo,Ying Zhou,Ying Shi,Gang Li,ShuFang Jiao,ZeJun Liu,WanNian Liang,HaiYan Wang.American Journal of Kidney Diseases . 2008 (3)